Publication related to RSI or an RSI staff member

Paediatric reference intervals and curves for haemoglobin and ferritin: protocol for a systematic review and meta-analysis.

Authors

  • Bijelic, Vid, Bijelic V, School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada vbije016@uottawa.ca.

  • Potter, Beth, Potter B, School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

  • Parkin, Patricia C, Parkin PC, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

  • Momoli, Franco, Momoli F, School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

  • Liebman, Mira, Liebman M, Department of Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

  • Hamid, Jemila S, Hamid JS, Department of Mathematics and Statistics, University of Ottawa, Ottawa, Ontario, Canada.

YEAR OF PUBLICATION: 2023
SOURCE: BMJ Open. 2023 Oct 4;13(10):e073783. doi: 10.1136/bmjopen-2023-073783.
JOURNAL TITLE ABBREVIATION: BMJ Open
JOURNAL TITLE: BMJ open
ISSN: 2044-6055 (Electronic) 2044-6055 (Linking)
VOLUME: 13
ISSUE: 10
PAGES: e073783
PLACE OF PUBLICATION: England
ABSTRACT:

INTRODUCTION: Reference intervals and reference curves provide clinicians with a point of reference when evaluating patients' laboratory test results. In practical applications, the 2.5th and 97.5th percentiles of healthy reference population are typically used as lower and upper reference limits. Guidelines outlining analytical and methodological steps involved in reference intervals and curves estimation are available and there have been large-scale world-wide initiatives to provide reference intervals and curves for children. However, there is a lack of synthesised evidence regarding the results of such initiatives in general, but specifically in iron-related biomarkers, ferritin (in serum and plasma) and haemoglobin. Objectives of this review are to identify studies that have produced reference intervals and curves for ferritin and haemoglobin in paediatric populations and to synthesise all available evidence. We also aim to quantify heterogeneity across reference intervals and curves and identify and elucidate sources of heterogeneity, including heterogeneity in the methods employed in their development. METHODS AND ANALYSIS: Using a comprehensive search strategy, we will identify eligible studies. Following electronic databases will be searched from inception: EMBASE, MEDLINE, SCOPUS and The Cochrane Library. We will also perform grey literature search to capture unpublished reference intervals and curves from healthy cohorts. Two researchers will independently screen retrieved citations against eligibility criteria in two stages, focusing first on titles and abstracts and then on full-text articles. Studies that provide reference intervals and curves for ferritin and haemoglobin for paediatric population will be eligible. Data extraction will include study characteristics, characteristics of reference population, methodological and analytical considerations and estimated reference intervals and curves. We will consider narrative synthesis and quantitative synthesis when appropriate. ETHICS AND DISSEMINATION: Ethical approval is not required as data from already published studies will be used. Results will be disseminated through peer-reviewed publications and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42023399802.

COPYRIGHT INFORMATION: (c) Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No||commercial re-use. See rights and permissions. Published by BMJ.
LANGUAGE: eng
DATE OF PUBLICATION: 2023 Oct 4
DATE OF ELECTRONIC PUBLICATION: 20231004
DATE COMPLETED: 20231006
DATE REVISED: 20231007
MESH DATE: 2023/10/06 06:43
EDAT: 2023/10/05 01:00
STATUS: MEDLINE
PUBLICATION STATUS: epublish
LOCATION IDENTIFIER: 10.1136/bmjopen-2023-073783 [doi] e073783
OWNER: NLM

Related RSI Experts

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli